Try our Advanced Search for more refined results

Gilead Seeks High Court Review Of Double-Patenting Row

By Allissa Wickham (December 5, 2014, 9:00 PM EST) -- Gilead Sciences Inc. has asked the U.S. Supreme Court to take up its case with Natco Pharma Ltd. over its planned generic version of Tamiflu, claiming the Federal Circuit's finding that a patent can be rendered invalid for double-patenting based on a patent that is filed after — but expires before — the first patent, flies in the face of well-established precedent....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!